Opioid effects on mitogen-activated protein kinase signaling cascades

Anesthesiology

Volumn 87, Issue 5, 1997, Pages 1118-1126

  Gutstein, Howard B ^a   Rubie, Elizabeth A ^b   Mansour, Alfred ^b   Akil, Huda ^b   Woodgett, James R ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

Dependence; Extracellular signal related kinase; Opiates; Opioid receptor; P38 mitogen activated protein kinase; Signal transduction; Stress activated protein kinase; Tolerance

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FENTANYL; KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; OPIATE DERIVATIVE; OPIATE RECEPTOR; PROTEIN P 38 KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COS CELLS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; NALOXONE; NARCOTICS; SIGNAL TRANSDUCTION;

EID: 0030827438     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199711000-00016     Document Type: Article

References (35)

1. Childers S: Opioid receptor-coupled second messenger systems, Handbook of Experimental Pharmacology: Opioids I. Edited by A. Herz. Berlin, Springer, 1993, pp 189-216
2. Reisine T, Pasternak G: Opioid analgesics and antagonists, The Pharmacological Basis of Therapeutics. Edited by J. Hardman, L. Limbird. New York, McGraw-Hill, 1996, pp 521-55
3. Nestler E: Molecular mechanisms of drug addiction. J Neurosci 1992; 12:2439-60
4. Nestler E: Under siege: the brain on opiates. Neuron 1996; 16:897-900
5. Maldonado R, Blendy J, Tzavara E, Gass P, Roques B, Hanoune J, Schutz G: Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 1996; 273:657-9
6. Chen L, Huang LM: Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron 1991; 7:319-26
7. Chen Y, Yu L: differential regulation by cAMP-dependent protein kinase and protein kinase C of the μ opioid receptor coupling to a G protein-activated K+ channel. J Biol Chem 1994; 269:7839-42
8. Trujillo KA, Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251:85-7
9. Cano E, Mahadevan L: Parallel signal processing among mammalian MAPKs. TIBS 1995; 20:117-22
10. Blumer K, Johnson G: Diversity in function and regulation of MAP kinase pathways. TIBS 1994; 19:236-40
11. Boulton T, Yancopoulos G, Gregory J, Slaughter C, Moomaw C, Hsu J, Cobb M: An insulin-stimulated protein kinase homologous to yeast kinases involved in cell cycle control. Science 1990; 249:64-7
12. Cobb M, Goldsmith E: How MAP kinases are regulated. J Biol Chem 1995; 270:14843-6
13. Marshall C: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-related kinase activation. Cell 1995; 80:179-85
14. Han J, Lee J, Bibbs L, Ulevitch R: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265:808-11
15. Kyriakis J, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad M, Avruch J, Woodgett J: The stress-activated protein kinase subfaminly of c-jun kinases. Nature 1994; 369:156-60
16. Lee J, Laydon J, McDonnell P, Gallagher T, Kumar S, Green D, McNulty D, Blumenthal M, Heys J, Landvatter S, Strickler J, McLaughlin M, Siemens I, Fisher S, Livi G, White J, Adams J, Young P: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-46
17. Crespo P, Xu N, Simonds W, Gutkind J: Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 1994; 369:418-20
18. Coso O, Teramoto H, Simonds W, Gutkind J: Signaling from G protein-coupled receptors to c-jun kinase involves βγ subunits of heterotrimeric G proteins acting on a ras and rac1-dependent pathway. J Biol Chem 1996; 271:3963-6
19. Liu J, Nickolenko J, Sharp FR: Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 1994; 91:8537-41
20. Hill C, Treisman R: Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995; 80:199-211
21. Meng F, Xie G-X, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H: Cloning and pharmacological characterization of a rat κ opioid receptor. Proc Natl Acad Sci USA 1993; 90:1255
22. Thompson RC, Mansour A, Akil H, Watson SJ: Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 1993; 11:903-13
23. Chen C, Okayama H: Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 1988; 6:632-8
24. Emmerson P, Clar M, Mansour A, Akil H, Woods J, Medzihradsky F: Characterization of opioid agonist efficacy in a C6 glioma cell line stably expressing the mu opioid receptor. J Pharm Exp Ther 1996; 278:1121-7
25. Adler V, Polotskaya A, Wagner F, Kraft A: Affinity-purified c-jun amino-terminal protein kinase requieres serine-threonine phosphoylation for activity. J Biol Chem 1992; 267:17001-5
26. Maruyama M, Sugino H, Akita H, Hatakana H: Binding characteristics of [3H] opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution. Brain Res 1987; 401:14-22
27. Akiyama K, Gee KW, Mosberg HI, Hruby VJ, Yamamura HI: Characterization of [3H] [2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to δ opiate receptors in the rat brain and neuroblastoma-glioma hybrid cell line (NG 108-15). Proc Natl Acad Sci USA 1985; 82:2543-7
28. Leysen JE, Gommeren W, Niemegeers CJE: [3H] Sufentanil, a superior ligand for μ-opiate receptors: binding properties and regional distribution in rat brain and spinal cord. Eur J Pharmacol 1983; 87:209-25
29. Berhow M, Hiroi N, Nestler E: Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rate mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 1996; 16:4707-15
30. Goldberg S, Woods J, Schuster C: Nalorphine-induced changes in morphine self-administration in rhesus monkeys. J Pharm Exp Ther 1971; 176:464-71
31. Mulé S: Effect of morphine and nalorphine on the metabolism of phospholipids in guinea pig cerebral cortex slices. J Pharm Exp Ther 1966; 154:370-83
32. Burt A, Carr I, Mullaney I, Anderson N, Milligan G: Agonist activation of p42 and p44 mitogen-activated protein kinases following the expression of the mouse δ receptor in rat-1 fibroblasts: effects of receptor expression levels and comparison with G-protein activation. Biochem J 1996; 320:227-35
33. Li L-Y, Chang K-J: The stimulatory effect of opioids on mitogen-activated protein kinase in chinese hamster ovary cells transfected to express μ-opioid receptors. Mol Pharmacol 1996; 50:599-602
34. Fukuda K, Kato S, Morikawa H, Shoda T, Mori K: Functional coupling of the ∂, μ, and κ opioid receptors to mitogen-activated protein kinase and arachidonate release in chinese hamster ovary cells. J Neurochem 1996; 67:1309-16
35. Ortiz J, Harris H, Guitart X, Terwilliger R, Haycock J, Nestler E: Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 1995; 15:1285-97